Top compounds associated with response to MED12L


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA WZ3105 GDSC1000 pan-cancer AAC 0.16 5e-07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.15 6e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 6e-07
mRNA PX-12 CTRPv2 pan-cancer AAC 0.14 8e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA SN-38 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 2e-06
Download CSV